Clinical Trial Update: Therapeutic Effect of Proliferative Therapy (Prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients With Anterior Disc Displacement With Reduction: A Randomized Clinical Trial . [Phase 2, Phase 3]

View source ↗

Summary

A randomized clinical trial comparing prolotherapy with hypertonic dextrose 25% versus 10% in retrodiscal tissues for anterior disc displacement with reduction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorders

Drugs mentioned

• Dextrose 10% solution for prolotherapy (Dextrose 10%)
• Hypertonic dextrose 25% for prolotherapy (Dextrose 25%)

Snippet

Sponsor: Cairo University | Conditions: TMJ Disc Disorder | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING